Local News What Happens if the Coronavirus’ Spikes Mutate?Fred Hutch | July 2, 2020The deaths, the economic crisis, the relentlessly rising number of COVID-19 cases — it all…emcguinnJuly 2, 2020 Read More
Local News Seattle Biotech Company Raises More Than $700M to Develop New Ways to Modify GenesGeekWire | July 2, 2020Sana Biotechnology today formally announced that it has raised more than $700 million in venture funding —…emcguinnJuly 2, 2020 Read More
Local News Improving Islet Transplantation to Treat Type I DiabetesInstitute for Stem Cell & Regenerative Medicine, UW | July 1, 2020Degenerative diseases come in many forms. When they strike, the root cause is essentially the…emcguinnJuly 1, 2020 Read More
Local News Sweet Way to 3D-Print Blood VesselsUW Medicine | July 1, 2020Powdered sugar is the special ingredient in a Rice University recipe for mimicking the body's…emcguinnJuly 1, 2020 Read More
Local News Antibodies a Hot Topic in COVID-19 ResearchFred Hutch | June 30, 2020Since the unwelcome arrival of COVID-19, a class of tiny, Y-shaped proteins in our blood…emcguinnJune 30, 2020 Read More
Local News Alzheimer’s Researchers Go Back to Basics to Find the Best Way ForwardNPR | June 29, 2020Three research institutions in Seattle have joined forces to study how Alzheimer's disease takes root…emcguinnJune 29, 2020 Read More
Local News Seattle Genetics Announces Initiation of Phase I Clinical Trials for Two Novel Antibody-Based Drug CandidatesBioSpace | June 26, 2020Seattle Genetics, Inc. have announced dosing of the first patient in a phase I clinical…emcguinnJune 26, 2020 Read More
Local News Study Yields Clues to How Drug May Boost Aged MitochondriaUW Medicine | June 25, 2020An experimental drug that has been shown to improve the function of diseased and aged…emcguinnJune 25, 2020 Read More
Local News AgeX Therapeutics and Pluristyx Announce Manufacturing, Marketing, and Distribution Agreement to Expand Access to Clinical-Grade Human Pluripotent Stem Cells for Therapeutic ApplicationsBioSpace | June 24, 2020AgeX Therapeutics, Inc.. (“AgeX”: NYSE American: AGE), a biotechnology company developing therapeutics for human aging…emcguinnJune 24, 2020 Read More
Local News AVM Biotechnology Hopeful for Their Unique Dexamethasone FormulationPR Newswire | June 24, 2020Oxford University announced yesterday that dexamethasone could reduce deaths in the sickest COVID-19 patients. The…emcguinnJune 24, 2020 Read More